Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
206.00    -0.20 (-0.10%)
Bid:
206.40
Ask:
206.80
Spread: 0.40 (0.194%)
Market Cap: £1.78b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
1st Mar 20239:00 amRNSTotal Voting Rights
2nd Feb 20233:25 pmRNSDirector/PDMR Shareholding
1st Feb 20231:29 pmRNSDirector/PDMR Shareholding
1st Feb 20239:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSTrading Statement
3rd Jan 20239:00 amRNSTotal Voting Rights
20th Dec 20229:05 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights
24th Nov 202210:46 amRNSDirector Declaration
16th Nov 20227:00 amRNSHalf-year results
8th Nov 20227:00 amRNSNotice of Results
1st Nov 20229:00 amRNSTotal Voting Rights
3rd Oct 202210:00 amRNSBlock listing Interim Review
3rd Oct 20229:00 amRNSTotal Voting Rights
30th Sep 20222:44 pmRNSDirector Declaration
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20222:41 pmRNSCompletion of The Spice Tailor acquisition
25th Aug 20227:00 amRNSDirector/PDMR Shareholding
24th Aug 202210:00 amRNSChange of Auditor
2nd Aug 20229:46 amRNSDirector Declaration
1st Aug 20229:00 amRNSTotal Voting Rights
29th Jul 202210:34 amRNSHolding(s) in Company
25th Jul 20227:00 amRNSAcquisition of The Spice Tailor
20th Jul 20224:07 pmRNSResult of AGM
20th Jul 20227:00 amRNSQ1 Trading Update
1st Jul 20228:30 amRNSTotal Voting Rights
22nd Jun 20223:05 pmRNSDividend Record Date Confirmation
10th Jun 20223:04 pmRNSDirector/PDMR Shareholding
6th Jun 202211:35 amRNSNotice of AGM
1st Jun 20229:00 amRNSTotal Voting Rights
27th May 202211:00 amRNSDirectorate Change
25th May 202212:25 pmRNSHolding(s) in Company
25th May 20227:00 amRNSHolding(s) in Company
19th May 202210:02 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSPreliminary Results
13th May 20222:21 pmRNSRemuneration Committee Chair
3rd May 20229:00 amRNSTotal Voting Rights
27th Apr 202212:14 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSDirectorate Change
21st Apr 20227:00 amRNSNotice of Results
8th Apr 20229:08 amRNSHolding(s) in Company
1st Apr 20228:24 amRNSBlock listing Interim Review
1st Apr 20228:00 amRNSTotal Voting Rights
10th Mar 20221:02 pmRNSNon-Executive Director Appointment
3rd Mar 202212:47 pmRNSDirector/PDMR Shareholding
1st Mar 20229:00 amRNSTotal Voting Rights
25th Feb 20222:29 pmRNSDirector/PDMR Shareholding
9th Feb 20223:17 pmRNSDirector/PDMR Shareholding
8th Feb 20222:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.